PASCAL Repair Reduces Tricuspid Regurgitation: CLASP TR Study MD Bureau9 April 2022 10:00 AM ISTTricuspid regurgitation (TR) is an increasingly prevalent valve disorder seen in the ageing population. Currently, there are no Class I indications...
Serum sodium at middle age associated with risk of developing HF- Good hydration prevents MD Editorial Team9 April 2022 9:00 AM ISTApproximately 550,000 new cases are diagnosed in the U.S. each year. Congestive heart failure affects people of all ages, from children and young...
Good hydration may reduce long-term risks for heart failure Dr. Kamal Kant Kohli7 April 2022 9:00 AM ISTStaying well-hydrated may be associated with a reduced risk for developing heart failure, according to researchers at the National Institutes of...
Tailored Electronic Health Record Improves Optimal Care For HF Patients: PROMPT-HF Trial MD Bureau7 April 2022 6:00 AM ISTHeart failure with reduced ejection fraction (HFrEF) is one of the most common chronic illnesses in the United States and carries a significant risk...
Omecamtiv mecarbil has Little Impact on Exercise Tolerance in HF patients: METEORIC-HF Trial Dr. Kamal Kant Kohli7 April 2022 6:00 AM ISTDURHAM, N.C.- Heart failure patients taking the investigational drug omecamtiv mecarbil experience little impact on their ability to exercise compared...
JBCPL gets trademark assignment of heart failure drug Azmarda from Novartis Roshni Dhar5 April 2022 5:45 PM ISTJB Chemicals and Pharmaceuticals (JBCPL) has recently announced that the company has approved the assignment of trademark for Azmarda indicated for...
Health Bulletin 5/April/2022 Roshni Dhar5 April 2022 5:25 PM ISTHere are the top health stories for the day:1 crore refunded to patients overcharged for Covid treatment at private hospitals The civic administration...
Low salt intake reduces HF symptoms, not ED visits: SODIUM-HF trial Dr. Kamal Kant Kohli4 April 2022 11:28 AM ISTFor longtime people with heart failure have been told to lower their salt intake, but until now there has been little scientific evidence behind the...
JBCPL gets trademark assignment of HF drug Azmarda from Novartis for Rs 246 crores Ruchika Sharma4 April 2022 11:22 AM ISTMumbai: JB Chemicals and Pharmaceuticals (JBCPL) has recently announced that the company has approved the assignment of trademark for Azmarda...
2022 heart failure guidelines issued by ACC, AHA, HFSA Dr. Kamal Kant Kohli4 April 2022 10:30 AM ISTThe American College of Cardiology, the American Heart Association, and the Heart Failure Society of America have issued 2022 guidelines on Management...
Atrial shunt device fails to improve health in heart failure with preserved EF: Lancet Medha Baranwal4 April 2022 9:00 AM ISTUSA: A recent study showed that the placement of an atrial shunt device did not improve health status or reduce the total rate of heart failure events...
Dr Reddy's Labs, Novartis ink pact for cardiovascular brand Cidmus Ruchika Sharma2 April 2022 12:03 PM ISTUnder the agreement, Dr Reddy's will be assigned and transferred the Cidmus trademark in India from Novartis AG for a consideration of USD 61 Million
